These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Long-term prognosis of childhood acute promyelocytic leukaemia with arsenic trioxide administration in induction and consolidation chemotherapy phases: a single-centre experience. Cheng Y; Zhang L; Wu J; Lu A; Wang B; Liu G Eur J Haematol; 2013 Dec; 91(6):483-9. PubMed ID: 24033687 [TBL] [Abstract][Full Text] [Related]
23. [Therapeutic strategies for patients with relapsed acute promyelocytic leukemia]. Ohnishi K Rinsho Ketsueki; 2006 Aug; 47(8):717-23. PubMed ID: 16986710 [No Abstract] [Full Text] [Related]
24. Autologous stem cell transplantation for patients with acute promyelocytic leukemia in second molecular remission. Ferrara F; Finizio O; Izzo T; Riccardi C; Criscuolo C; Carbone A; Borlenghi E; Rossi G Anticancer Res; 2010 Sep; 30(9):3845-9. PubMed ID: 20944181 [TBL] [Abstract][Full Text] [Related]
25. [Interpretation of the expert Chinese guideline for diagnosis and treatment of acute promyelocytic leukemia (2014)]. Shen Z Zhonghua Xue Ye Xue Za Zhi; 2014 May; 35(5):478. PubMed ID: 24857228 [No Abstract] [Full Text] [Related]
27. Leukemic relapse in host cells almost 7 years after bone marrow transplantation for acute promyelocytic leukemia in first complete remission. Kamani N; Lange B; August CS; Nowell P Bone Marrow Transplant; 1989 Jul; 4(4):455-6. PubMed ID: 2673469 [No Abstract] [Full Text] [Related]
28. Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet. Lengfelder E; Lo-Coco F; Ades L; Montesinos P; Grimwade D; Kishore B; Ramadan SM; Pagoni M; Breccia M; Huerta AJ; Nloga AM; González-Sanmiguel JD; Schmidt A; Lambert JF; Lehmann S; Di Bona E; Cassinat B; Hofmann WK; Görlich D; Sauerland MC; Fenaux P; Sanz M; Leukemia; 2015 May; 29(5):1084-91. PubMed ID: 25627637 [TBL] [Abstract][Full Text] [Related]
29. Same sibling marrow following cord allogeneic transplantation as therapy for second relapse acute promyelocytic leukemia in a pediatric patient. De Oliveira SN; Kao RL; Pham A; Smith LT; Kempert P; Moore TB Pediatr Transplant; 2016 Mar; 20(2):337-41. PubMed ID: 26849401 [TBL] [Abstract][Full Text] [Related]
30. Central nervous system relapse occurs in about 5% of cases of acute promyelocytic leukaemia. Castagnola C; Elena C; Merli M Haematologica; 2008 Feb; 93(2):e28. PubMed ID: 18245644 [TBL] [Abstract][Full Text] [Related]
31. Isolated central nervous system recurrence of acute promyelocytic leukemia in children. Chow J; Feusner J Pediatr Blood Cancer; 2009 Jan; 52(1):11-3. PubMed ID: 18816805 [TBL] [Abstract][Full Text] [Related]
32. Acute leukemia of donor origin arising after stem cell transplantation for acute promyelocytic leukemia. Daly AS; Kamel-Reid S; Lipton JH; Messner HA; Kiss TL; Chun K; Busque L; Chang H Leuk Res; 2004 Oct; 28(10):1107-11. PubMed ID: 15289025 [TBL] [Abstract][Full Text] [Related]
33. Role of autologous bone marrow transplantation as consolidation therapy in acute promyelocytic leukemia patients in complete remission. Ottaviani E; Martinelli G; Testoni N; Visani G; Tani M; Tura S Haematologica; 1998 Nov; 83(11):1051-5. PubMed ID: 9864933 [TBL] [Abstract][Full Text] [Related]
34. Economic evaluation of arsenic trioxide compared to all-trans retinoic acid + conventional chemotherapy for treatment of relapsed acute promyelocytic leukemia in Canada. Lachaine J; Mathurin K; Barakat S; Couban S Eur J Haematol; 2015 Sep; 95(3):218-29. PubMed ID: 25354894 [TBL] [Abstract][Full Text] [Related]
35. Central nervous system relapse in acute promyelocytic leukemia: a single institution experience. Gupta V; Gonsalves W; Patnaik M; Gangat N Leuk Lymphoma; 2013 Dec; 54(12):2728-30. PubMed ID: 23469963 [No Abstract] [Full Text] [Related]